Search research articles
Contact Us
Filters
Showing results (41-50 of 114) with videos related to
Page
of 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2011
Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts
M Reck, F Barlesi, L Crinò, et al.
ESMO Open
|
December 18, 2021
First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association of Thoracic Oncology
C Gridelli, S Peters, T Mok, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2004
SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results
M E R O'Brien, H Anderson, E Kaukel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2011
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer
M Reck, R Kaiser, C Eschbach, et al.
Pathology Oncology Research : POR
|
March 11, 2014
Transforming growth factor-beta signaling leads to uPA/PAI-1 activation and metastasis: a study on human breast cancer tissues
D S Lang, S Marwitz, U Heilenkötter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2005
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma
C Manegold, J Symanowski, U Gatzemeier, et al.
Organic & Biomolecular Chemistry
|
April 23, 2015
Synthesis of new carolacton derivatives and their activity against biofilms of oral bacteria
N Stumpp, P Premnath, T Schmidt, et al.
The European Respiratory Journal
|
February 17, 2006
Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer
R M Huber, M Reck, H Gosse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2021
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>
S Popat, P Baas, C Faivre-Finn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2010
Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding study
M Ranson, M Reck, A Anthoney, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 114) with videos related to
Sort By:
Page
of 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2011
Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts
M Reck, F Barlesi, L Crinò, et al.
ESMO Open
|
December 18, 2021
First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association of Thoracic Oncology
C Gridelli, S Peters, T Mok, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 21, 2004
SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results
M E R O'Brien, H Anderson, E Kaukel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2011
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer
M Reck, R Kaiser, C Eschbach, et al.
Pathology Oncology Research : POR
|
March 11, 2014
Transforming growth factor-beta signaling leads to uPA/PAI-1 activation and metastasis: a study on human breast cancer tissues
D S Lang, S Marwitz, U Heilenkötter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2005
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma
C Manegold, J Symanowski, U Gatzemeier, et al.
Organic & Biomolecular Chemistry
|
April 23, 2015
Synthesis of new carolacton derivatives and their activity against biofilms of oral bacteria
N Stumpp, P Premnath, T Schmidt, et al.
The European Respiratory Journal
|
February 17, 2006
Efficacy of a toxicity-adjusted topotecan therapy in recurrent small cell lung cancer
R M Huber, M Reck, H Gosse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2021
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>
S Popat, P Baas, C Faivre-Finn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2010
Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding study
M Ranson, M Reck, A Anthoney, et al.
Page
of 12